Blue Light Therapy for Rib Fractures
(BLAASTT Trial)
Trial Summary
What is the purpose of this trial?
The main goal of this clinical trial is to learn if light therapy improves pain and inflammation in adults with painful rib fractures. The main question it aims to answer is: - Does bright blue light therapy in addition to standard pain treatments improve pain with breathing in adults with painful rib fractures? Researchers will compare participants who receive bright blue light therapy to participants who receive white light therapy and participants who receive only usual lighting conditions to look for differences in their pain control. In addition to their assigned light treatment, all participants will receive standard pain control treatments. Participants will be assigned randomly to one of three groups: one-third will be assigned to bright blue light therapy, one-third will be assigned to bright white light therapy, and one-third will be assigned to usual light only. They will receive their assigned light treatment for 4 hours during the morning/early afternoon for up to 3 days while they are in the hospital. On each day they receive the light treatment and on the day after their final light treatment: * They will be asked twice to rate their pain at rest and with taking a deep breath. * They will be tested to confirm that they are not experiencing delirium, or confusion related to being in the hospital. * They will be asked to wear a heart monitor to look for changes in their heart rate. * Blood samples will be collected to look for changes in inflammation and the circadian clock, the body's natural 24-hour cycle.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems that participants will continue with standard pain treatments alongside the light therapy.
How is Blue Light Therapy different from other treatments for rib fractures?
Blue Light Therapy is unique because it uses light to potentially aid in healing rib fractures, unlike traditional treatments that often focus on pain management and physical support. This approach is non-invasive and does not rely on medication, which may offer an alternative for those seeking non-drug options.12345
Research Team
Rebecca E Kotcher, MD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
Adults with painful rib fractures may join this trial. They must be hospitalized and willing to undergo light therapy alongside standard pain treatments. However, individuals who might experience confusion (delirium) due to hospitalization or have conditions that could interfere with the study are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive assigned light therapy for 4 hours during the morning/early afternoon for up to 3 days while in the hospital
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a follow-up phone call at 30 days
Treatment Details
Interventions
- Blue Light
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rebecca E Kotcher, MD
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
National Institutes of Health (NIH)
Collaborator